🇺🇸 FDA
Pipeline program

GEMCITABINE

2016-004017-27

Phase 2 small_molecule active

Quick answer

GEMCITABINE for Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cell carcinoma is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cell carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials